Public annual accounts

NUTRIFARMA financials

Name: NUTRIFARMA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for NUTRIFARMA, with comparable measures and links to available source documents.

Company overview

Registry number

0458087349

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for NUTRIFARMA

2025 versus 2024

Operating line: €648,138
EBITDA: €220,294
Total assets: €1,802,858
Equity: €1,395,533

EBITDA margin +34% · Equity ratio +77.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€648,138	€220,294	€1,802,858	€1,395,533	-
202431 Dec 2024	€541,295	€176,384	€1,546,519	€1,301,197	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report